Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Tissue expansion surgery generally improves quality of life in children, especially for scars and alopecia.

Both EQ-5D-5L and SF-6DV2 are valid for measuring health but can't be used interchangeably.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health issues.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

There is a need for better treatments for severe alopecia areata.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

People with alopecia areata face challenges but find ways to cope and live fulfilling lives.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Long COVID care improved the patient's mobility, breathing, anxiety, and social relationships.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Improving symptoms of male urinary problems may lower the risk of death.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.